18F-FMAU PET/CT

N/A

Report date: 2025/11/28 15:16:07
NME

Base Information

Drug Name18F-FMAU PET/CT
Drug Alias NameFluorine F 18 d-FMAUL-[18F]FMAU[18F]-L-FMAU[18F]-FMAU
ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5] 
Mechanisms of ActionPositron-emission tomography enhancersRadionuclide imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsBrain metastasesMetastatic breast cancerSkin Melanoma +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas At Austin
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Southern California
Inactive CompaniesN/A
Active IndicationsBrain metastasesMetastatic breast cancerSkin Melanoma +[11] 
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A